Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 21.15B P/E 36.05 EPS this Y 455.60% Ern Qtrly Grth -48.10%
Income 139.73M Forward P/E 31.91 EPS next Y 18.70% 50D Avg Chg 4.00%
Sales 3.01B PEG -6.59 EPS past 5Y -15.75% 200D Avg Chg -10.00%
Dividend 4.00% Price/Book 1.13 EPS next 5Y -5.92% 52W High Chg -29.00%
Recommedations 2.20 Quick Ratio 2.67 Shares Outstanding 174.93M 52W Low Chg 12.00%
Insider Own 0.94% ROA 1.35% Shares Float 172.61M Beta 1.17
Inst Own 95.50% ROE 1.49% Shares Shorted/Prior 2.81M/2.53M Price 122.22
Gross Margin 70.88% Profit Margin 5.09% Avg. Volume 1,004,537 Target Price 136.58
Oper. Margin 27.94% Earnings Date Oct 21 Volume 854,838 Change 0.13%
About Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. Alexandria has a total market capitalization of $34.4 billion and an asset base in North America of 74.1 million SF as of March 31, 2024, which includes 42.2 million RSF of operating properties, 5.3 million RSF of Class A/A+ properties undergoing construction and one committed near-term project expected to commence construction in the next two years, 2.5 million RSF of priority anticipated development and redevelopment projects, and 24.1 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

Alexandria Real Estate Equities News
12/11/24 Mid-America Announces 3.1% Hike in Dividend: Is It Sustainable?
12/11/24 Alexandria Real Estate Equities, Inc. to Hold Its Fourth Quarter and Year End 2024 Operating and Financial Results Conference Call and Webcast on January 28, 2025
12/10/24 Alexandria Hikes Dividend by 1.5%, Announces $500M Stock Buyback Plan
12/10/24 Alexandria Real Estate's $500M Buyback and Dividend Hike: A Game-Changer for Investors?
12/09/24 Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.32 per Common Share for 4Q24, an Increase of 2 Cents Over 3Q24, and an Aggregate of $5.19 per Common Share for 2024, an Increase of 23 Cents, or 5 Percent, Over 2023
12/09/24 Alexandria Real Estate Equities, Inc. Announces $500 Million Common Stock Repurchase Program
11/29/24 Black Friday Stock Sale: Down 12% to 25%, These 3 Dividend Stocks Are Great Bargain Buys Right Now
11/28/24 Alexandria Real Estate price target lowered to $119 from $121 at Evercore ISI
11/27/24 J.P. Morgan Downgrades Alexandria Real Estate on Soft Life Sciences Leasing Demand
11/27/24 Is it Wise to Retain Alexandria Stock in Your Portfolio Now?
11/22/24 Alexandria Announces Long-Term Lease at San Carlos Mega Campus
11/21/24 Alexandria Real Estate Equities, Inc. Announces Long-Term 258,581 RSF Lease With Longstanding Tenant Vaxcyte, Inc. at the Alexandria Center for Life Science - San Carlos Mega Campus
11/06/24 Alexandria Real Estate Equities, Inc. Enables the Discovery, Development and Delivery of New Innovative Medicines That Are Key to Addressing Significant Unmet Medical Need
10/23/24 Q3 2024 Alexandria Real Estate Equities Inc Earnings Call
10/23/24 Alexandria Real Estate Equities Inc (ARE) Q3 2024 Earnings Call Highlights: Strong Leasing ...
10/22/24 Alexandria Q3 AFFO Misses Estimates, Revenues Increase Y/Y
10/22/24 Decoding Alexandria Real Estate Equities Inc (ARE): A Strategic SWOT Insight
10/21/24 Compared to Estimates, Alexandria Real Estate Equities (ARE) Q3 Earnings: A Look at Key Metrics
10/21/24 Alexandria Real Estate Equities (ARE) Q3 FFO Miss Estimates
10/21/24 Alexandria Real Estate Equities: Q3 Earnings Snapshot
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Cunningham John H EVP - Regional Marke.. EVP - Regional Market Director Feb 07 Sell 165.78 7,800 1,293,084 62,586 02/09/23
MARCUS JOEL S Executive Chairman Executive Chairman Feb 07 Sell 168 9,000 1,512,000 388,729 02/09/23
Binda Marc E EVP - Finance & Trea.. EVP - Finance & Treasurer Feb 06 Sell 167.21 3,298 551,459 67,005 02/08/23
Lee Orraparn C. EVP - Accounting EVP - Accounting Feb 06 Sell 167.11 4,800 802,128 33,619 02/08/23
Kass Hunter EVP - Regional Marke.. EVP - Regional Market Director Feb 06 Sell 167.45 3,803 636,812 87,850 02/08/23
CIRUZZI VINCENT Chief Development Of.. Chief Development Officer Aug 11 Sell 167.83 2,016 338,345 51,929 08/15/22
Freire Maria C Director Director Jul 28 Sell 163.82 2,600 425,932 2,711 08/01/22
Cain James P Director Director Mar 16 Sell 193.26 425 82,136 4,883 03/18/22
Diamond Lawrence J Co-Chief Operating O.. Co-Chief Operating Officer Feb 24 Sell 190.21 3,950 751,330 91,717 02/28/22
Hakman Joseph Co-Chief Operating O.. Co-Chief Operating Officer Feb 18 Sell 186 2,435 452,910 36,883 02/23/22
CIRUZZI VINCENT Chief Development Of.. Chief Development Officer Feb 18 Sell 185.68 3,593 667,148 52,002 02/23/22
Moglia Peter M Co-Chief Executive O.. Co-Chief Executive Officer Feb 16 Sell 186.02 5,500 1,023,110 174,988 02/18/22
Kass Hunter EVP - Regional Marke.. EVP - Regional Market Director Feb 16 Sell 184.96 5,544 1,025,418 41,105 02/18/22